Scarica l'app Stockscreener
52.67
0.60%
-0.38
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MIRM Giù?
Forum
Previsione
Precedente Chiudi:
$53.05
Aprire:
$53.12
Volume 24 ore:
91,297
Relative Volume:
0.22
Capitalizzazione di mercato:
$2.61B
Reddito:
$379.25M
Utile/perdita netta:
$-77.34M
Rapporto P/E:
-32.67
EPS:
-1.6122
Flusso di cassa netto:
$-27.87M
1 W Prestazione:
+0.00%
1M Prestazione:
+3.17%
6M Prestazione:
+10.94%
1 anno Prestazione:
+34.96%
Intervallo 1D:
$52.72
$53.78
Intervallo di 1 settimana:
$50.96
$53.78
Portata 52W:
$36.20
$54.78
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Nome
Mirum Pharmaceuticals Inc
Settore
Industria
Telefono
650-667-4085
Indirizzo
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Confronta MIRM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
52.72 | 2.59B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.38 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.62 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.10 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
584.55 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.17 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-19 | Ripresa | H.C. Wainwright | Buy |
| 2024-04-17 | Iniziato | Stifel | Buy |
| 2023-12-18 | Reiterato | H.C. Wainwright | Buy |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-11-13 | Iniziato | Morgan Stanley | Overweight |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-10-17 | Ripresa | Evercore ISI | Outperform |
| 2023-09-20 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-01 | Iniziato | Citigroup | Buy |
| 2021-09-20 | Iniziato | JP Morgan | Overweight |
| 2020-08-07 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-31 | Iniziato | Piper Sandler | Overweight |
| 2020-06-25 | Iniziato | Robert W. Baird | Outperform |
| 2019-08-12 | Iniziato | Citigroup | Buy |
| 2019-08-12 | Iniziato | Evercore ISI | Outperform |
| 2019-08-12 | Iniziato | Guggenheim | Buy |
| 2019-08-12 | Iniziato | ROTH Capital | Buy |
| 2019-08-12 | Iniziato | Raymond James | Outperform |
Mostra tutto
Mirum Pharmaceuticals Inc Borsa (MIRM) Ultime notizie
What drives Mirum Pharmaceuticals Inc. stock priceMassive profits - Autocar Professional
What analysts say about Mirum Pharmaceuticals Inc. stockMarket-leading growth rates - jammulinksnews.com
Is Mirum Pharmaceuticals Inc. a good long term investmentFree Investment Risk Control - jammulinksnews.com
Mirum Pharmaceuticals Inc. Stock Analysis and ForecastSuperior investment outcomes - jammulinksnews.com
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - MSN
Purpose, not just product: What sets Mirum apart - Endpoints News
Bank of New York Mellon Corp Acquires 122,402 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2025 Earnings Call Transcript - MSN
Mirum Pharma’s Rare Disease Bets Are Paying Off For Investors - Finimize
Teacher Retirement System of Texas Sells 925 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals Advances Phase 3 Study on Maralixibat for Cholestatic Pruritus - TipRanks
When the Price of (MIRM) Talks, People Listen - news.stocktradersdaily.com
How Mirum Pharmaceuticals Inc. stock performs during market volatilityEntry Level Low Risk Picks - Newser
What makes Mirum Pharmaceuticals Inc. stock price move sharplyFree Access to Investment Community - Newser
Why Mirum Pharmaceuticals Inc. stock attracts strong analyst attentionMarket Beating Strategy - Newser
Mirum Pharmaceuticals stock hits all-time high at $54.46 - Investing.com Australia
Mirum Hits All-Time HighIs There More Upside Ahead? - RTTNews
Mirum Pharmaceuticals stock hits all-time high at $54.46 By Investing.com - Investing.com South Africa
Mirum Pharmaceuticals price target raised to $76 from $68 at Evercore ISI - MSN
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
KBC Group NV Makes New Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Top Analyst Ratings From Last Week - The Globe and Mail
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Is Breakeven Near? - 富途牛牛
Mirum Pharmaceuticals (NASDAQ:MIRM) Lowered to Hold Rating by Wall Street Zen - Defense World
Mirum Pharmaceuticals beats Q1 estimates, raises 2025 guidance; shares rise - Investing.com Nigeria
Wealth Enhancement Advisory Services LLC Purchases 339 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals Insiders Sold US$2.2m Of Shares Suggesting Hesitancy - simplywall.st
Mirum Pharmaceuticals, Inc.(NasdaqGM: MIRM) dropped from Russell 3000E Index - MarketScreener
Mirum Pharmaceuticals, Inc.(NasdaqGM: MIRM) dropped from Russell Microcap Index - MarketScreener
When (MIRM) Moves Investors should Listen - news.stocktradersdaily.com
Rhumbline Advisers Purchases 2,321 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Where are the Opportunities in (MIRM) - news.stocktradersdaily.com
Mirum Pharmaceuticals Inc Azioni (MIRM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.06%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):